Seiji Nishino

Seiji Nishino is a Japanese neuroscientist and writer.[1] He is a professor emeritus of psychiatry and behavioral sciences at the Stanford University.[2][3] He is also the director of Stanford Center for Sleep Sciences and Medicine.[4][5]

Nishino, a well-known sleep researcher,[6] he researches sleep disorders, sleep and circadian physiology using animal models.[7] Since 2016, he has been director of Good Quality Sleep Research Organization.[8]

He is also the author of a best-selling Japanese book on sleep.[9]

Early life and career

Born in Kawachinagano, Osaka Prefecture in 1955, Nishino studied at Osaka Kyoiku University High School Tennoji school.[10] He graduated from Osaka Medical College.[10]

In 1987, he joined the Stanford Center for Sleep Sciences and Medicine at Stanford University.[11]

In 1999, he discovered the causative gene in canine familial narcolepsy.[8]

In 2000, he identified the main developmental mechanism of human narcolepsy as the center of the group.[8]

In 2005, Nishino became director of the Stanford Institute for Sleep and Biological Rhythms.[8]

In 2007, he became professor of psychiatry at the University of Stanford.

Bibliography

  • Nishino, Seiji; Sakurai, Takeshi (22 November 2007). The Orexin/Hypocretin System: Physiology and Pathophysiology (Contemporary Clinical Neuroscience)
  • Seiji, Nishino. The Stanford Method for Ultimate Sound Sleep (スタンフォード式 最高の睡眠, sutanfo-do shiki saikou no suimin, 5 March 2017)
  • Seiji, Nishino (18 March 2020). El arte del descanso: Descubre el método para dormir bien y descansar mejor (Spanish Edition)
  • Seiji, Nishino (1 November 2020). Stanford Sleeping Habits (Chinese Edition)

Select publications

  • High rebound mattress toppers facilitate core body temperature drop and enhance deep sleep in the initial phase of nocturnal sleep [12]
  • An overview of hypocretin based therapy in narcolepsy [12]
  • Advances in pharmaceutical treatment options for narcolepsy [12]
  • Low dose of aripiprazole advanced sleep rhythm and reduced nocturnal sleep time in the patients with delayed sleep phase syndrome: an open-labeled clinical observation [12]
  • Mast cell involvement in glucose tolerance impairment caused by chronic mild stress with sleep disturbance [12]
  • N-Methyl-D-aspartate receptor antibody could be a cause of catatonic symptoms in psychiatric patients: case reports and methods for detection [12]
  • Wake-promoting effects of ONO-4127Na, a prostaglandin DP1 receptor antagonist, in hypocretin/orexin deficient narcoleptic mice [12]
  • Decline of CSF orexin (hypocretin) levels in Prader-Willi syndrome [12]
  • A PERIOD3 variant causes a circadian phenotype and is associated with a seasonal mood trait [12]

Awards

  • Narcolepsy Network Scientist Award
  • NIH Mentored Research Scientist Developmental Award
  • David Amar Israel Sleep Research Society Award

References

Other sources

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.